PharmaKinnex LIVE Rep - Live Interactive Virtually Enhanced Representative

PharmaKinnex is a privately owned multi-channel direct marketing company providing tactical services in the execution of targeted, messaging programs. Our single focus is supporting pharmaceutical/biotech companies with message reach and frequency to their healthcare targets. 

Are you looking for a better way to interact and engage with your most important targets?

PharmaKinnex Combining the Best features of Pharmaceutical Teledetailing and eDetailing and now offer the Only Web Enabled Detail Featuring Live Two-Way Interaction. LIVE Rep is a digital selling solution that connects physicians to an Inside or Outside Sales Representative via a secure web-based platform. LIVE Rep combine the value of live two-way interaction with the efficiency and convenience of traditional eDetailing programs. Physicians engage in a one-on-one product discussion facilitated by your unique product related content. LIVE Rep is a better way to engage and motivate your targets to prescribe your brand.

A Major Improvement Over Traditional eDetailing Programs

• Interactions include a live telephone call and interactive digital media presentation
• Interactions are led by field based and/or call center representatives
• A dashboard is provided to guide the sales professional in presenting the most appropriate material during the interaction and to plan for the next interaction
• Interactions include a post call survey to evaluate physician satisfaction
• A dashboard is provided to sales and marketing leadership to evaluate the success of the program

Read Original Source 

Customized Pharmaceutical Fulfillment Services from PharmaKinnex, NJ

New Jersey based, PharmaKinnex offers fully integrated pharmaceutical fulfillment services compliant with the regulations that govern the fulfillment of marketing materials & samples. Today, no one channel can be relied on to effectively satisfy the communication preferences of all healthcare providers. A diverse multi-channel approach works best to optimize reach and frequency and drive information and sample requests. For more information call us on: (732) 613-4422 or visit: http://pharmakinnex.com/pharmaceutical-fulfillment

PharmaKinnex Provides Integrated Pharmaceutical Fulfillment Services

PharmaKinnex provides seamless, quality, timely, pharmaceutical fulfillment services as a stand-alone service or as part of a highly-effective multi-channel marketing approach. Our fully integrated fulfillment services provide the convenience of handling your project from start to finish. Our company is founded by pharmaceutical marketing executives who know this business and understand the demands of our clients. PharmaKinnex has expert knowledge of:

• PDMA guidelines
• State license validation
• Acknowledgment of content and signature audits required for compliant Rx sample distribution.

Requests for fulfillment are customized to the recipient. Any variety of RX/OTC samples, educational and promotional items may be distributed. PharmaKinnex can fulfill:

• Direct to your pharmaceutical sales representatives
• Direct to your targeted healthcare providers, or
• Both

Call PharmaKinnex today at (732) 387-5042 to explore the features and benefits of working with one fully integrated pharmaceutical multi-channel marketing and fulfillment company.

Pharmaceutical Marketing Mix

Employ a Strong Marketing Mix with Pharmaceutical Vacant Territory Programs. What happens if your pharmaceutical marketing mix is not properly delivered to your targets for three months, six months, or more? PharmaKinnex Vacant Territory programs provide a quickly deployed, optimized pharmaceutical marketing mix to maintain and increase your share of voice when face-to-face meetings are not an option. The key is to quickly deliver:

• The right message mix
• Through the right channels
• To the right healthcare target

Read more about Marketing Mix Here-http://pharmakinnex.com/pharmaceutical-vacant-territory

 

FDA To Survey Medical Professionals About Effects of Pharmaceutical Marketing

Source: http://www.raps.org/focus-online/news/news-article-view/article/3209/fda-gets-go-ahead-for-study-of-dtc-advertising-and-social-media.aspx

The Food and Drug Administration (FDA) has received approval from President Obama to conduct a two-year, $365,000 survey of America’s medical professionals to determine the influence of pharmaceutical marketing.  Physicians, nurse practitioners and physician assistants will be surveyed on their opinions about how drugs are marketed to consumers and healthcare providers.  The survey appears to be especially focused on direct-to-consumer (DTC) advertising and potentially social media.

Three Thoughts on the FDA Survey:

1.      If the FDA wants to understand the positive/negative influence of direct-to-consumer ads shouldn’t they also survey some consumers?  A patient who was motivated to visit their doctor about a previously untreated and potentially dangerous disease might offer a different perspective than his physician, who may have been annoyed that the patient requested or asked about a specific drug for his untreated disease.  In other words, will the doctor necessarily answer the survey in a way that sheds light on the real value of a DTC ad?

2.      Billions are spent each year in the U.S. on pharmaceutical marketing initiatives and the FDA is likely seeking to determine if these marketing programs are a negative influence on prescribing habits.  With voluntary PhRMA codes, the Sunshine Act, and other state and federal legislation, it has become much more challenging and expensive in recent years for pharmaceutical companies to market their products.  Will the FDA’s new survey lead to more regulations for pharmaceutical marketers?

3.      As government agencies seek to regulate pharmaceutical marketers it is important that they not blindly discount the value that pharmaceutical marketing brings in terms of disease awareness to physicians and patients, and education about medications that are used every day.  Certainly, there have been some abuses by pharmaceutical marketers, but these represent a tiny minority of pharmaceutical sales and marketing initiatives.  However, physicians are very busy and a short visit with a pharmaceutical sales representative or a teledetailing call can provide life-saving reminders about drug side effects and drug-to-drug interactions; And DTC drug ads can help undiagnosed or untreated patients to visit their doctor.  Does anybody believe the FDA survey will capture the benefits of pharmaceutical marketing, especially if healthcare providers are the only subjects interviewed?

Reasons why some Pharmaceutical Telemarketing Programs work, while others Fail

Many times it happens that pharmaceutical telemarketing program don’t work. It may be because of various reasons. Below is the brief overview of how we can design a successful pharmaceutical teledetailing program so that it works.

Well defined Objective: Pharmaceutical Teledetailing Program must have well defined objective. Like any marketing program if you don’t know what you want to achieve you probably aren’t going to be happy with the results.

Supportive Materials or Prescription Samples: Pharmaceutical Teledetailing Program must have Supportive Materials or Prescription Samples. If the teledetail representative doesn’t have an incentive to offer it will be a huge challenge to get a physician or nurse onto the telephone.

Multi-Channel Pharmaceutical Marketing: Pharmaceutical Teledetailing Program must have Multi-Channel Pharmaceutical Marketing approach. It includes fax, email, edetailing, direct mail and other channels. A multi-channel approach gives you the best chance at reaching all of your targets.

Read Original Source